Taiwo B - Search Results

1

Transmitted antiretroviral drug resistance in newly HIV-infected and untreated patients in Ségou and Bamako, Mali.

Maiga AI, Fofana DB, Maiga AC, Diallo F, Ait-Arkoub Z, Daou F, Cisse M, Sarro YD, Oumar AA, Sylla A, Katlama C, Taiwo B, Murphy R, Tounkara A, Marcelin AG, Calvez V. Maiga AI, et al. Among authors: taiwo b. AIDS Res Hum Retroviruses. 2013 Jan;29(1):182-6. doi: 10.1089/AID.2012.0118. Epub 2012 Aug 27. AIDS Res Hum Retroviruses. 2013. PMID: 22823755 Free PMC article.

2

Transmitted Resistance: An Overview and Its Potential Relevance to the Management of HIV-Infected Persons in Resource-Limited Settings.

Taiwo BO, Murphy R. Taiwo BO, et al. J Int Assoc Physicians AIDS Care (Chic). 2007 Sep;6(3):188-97. doi: 10.1177/1545109707300683. Epub 2007 May 1. J Int Assoc Physicians AIDS Care (Chic). 2007. PMID: 17473177

3

Clinical applications and availability of CD4+ T cell count testing in sub-Saharan Africa.

Taiwo BO, Murphy RL. Taiwo BO, et al. Cytometry B Clin Cytom. 2008;74 Suppl 1:S11-8. doi: 10.1002/cyto.b.20383. Cytometry B Clin Cytom. 2008. PMID: 18061953 Free article. Review.

4

Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen.

Gerschenson M, Kim C, Berzins B, Taiwo B, Libutti DE, Choi J, Chen D, Weinstein J, Shore J, da Silva B, Belsey E, McComsey GA, Murphy RL. Gerschenson M, et al. Among authors: taiwo b. J Antimicrob Chemother. 2009 Jun;63(6):1244-50. doi: 10.1093/jac/dkp100. Epub 2009 Mar 25. J Antimicrob Chemother. 2009. PMID: 19321503 Free PMC article.

5

Outcomes for therapeutic vaccines trials.

Taiwo B, Murphy R. Taiwo B, et al. Curr Opin HIV AIDS. 2006 Nov;1(6):502-6. doi: 10.1097/01.COH.0000250321.50408.0a. Curr Opin HIV AIDS. 2006. PMID: 19372853

6

Suboptimal etravirine activity is common during failure of nevirapine-based combination antiretroviral therapy in a cohort infected with non-B subtype HIV-1.

Taiwo B, Chaplin B, Penugonda S, Meloni S, Akanmu S, Gashau W, Idoko J, Adewole I, Murphy R, Kanki P. Taiwo B, et al. Curr HIV Res. 2010 Apr;8(3):194-8. doi: 10.2174/157016210791111098. Curr HIV Res. 2010. PMID: 20163340

7

Assessing the viorologic and adherence benefits of patient-selected HIV treatment partners in a resource-limited setting.

Taiwo BO, Idoko JA, Welty LJ, Otoh I, Job G, Iyaji PG, Agbaji O, Agaba PA, Murphy RL. Taiwo BO, et al. J Acquir Immune Defic Syndr. 2010 May 1;54(1):85-92. doi: 10.1097/01.qai.0000371678.25873.1c. J Acquir Immune Defic Syndr. 2010. PMID: 20418724 Clinical Trial.

8

Patient-selected treatment partners did not protect against drug resistance during first-line NNRTI-based HAART in a randomized trial.

Taiwo BO, Idoko JA, Marcelin AG, Otoh I, Reddy S, Iyaji PG, Agbaji O, Penugonda S, Agaba PA, Murphy RL. Taiwo BO, et al. J Acquir Immune Defic Syndr. 2010 Aug;54(5):563-5. doi: 10.1097/QAI.0b013e3181e5112f. J Acquir Immune Defic Syndr. 2010. PMID: 20647829 Clinical Trial. No abstract available.

9

Novel antiretroviral combinations in treatment-experienced patients with HIV infection: rationale and results.

Taiwo B, Murphy RL, Katlama C. Taiwo B, et al. Drugs. 2010 Sep 10;70(13):1629-42. doi: 10.2165/11538020-000000000-00000. Drugs. 2010. PMID: 20731472 Review.

10

Temporal changes in renal glomerular function associated with the use of Tenofovir Disoproxil Fumarate in HIV-infected Nigerians.

Agbaji OO, Agaba PA, Idoko JA, Taiwo B, Murphy R, Kanki P, Ekong E. Agbaji OO, et al. Among authors: taiwo b. West Afr J Med. 2011 May-Jun;30(3):164-8. West Afr J Med. 2011. PMID: 22120479

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters